Previous Article | Next Article ![]()
Journal of Clinical Microbiology, Oct 1995, 2732-2737, Vol 33, No. 10
R Le Guennec, J Reynes, M Mallie, C Pujol, F Janbon and JM Bastide
Multilocus enzyme electrophoresis and in vitro susceptibility testing with
a broth microdilution method were used to analyze Candida albicans strain
diversity in four AIDS patients with recurrent oropharyngeal candidiasis
who successively developed clinical resistance to fluconazole (FCZ) and
itraconazole (ITZ). One to ten colonies per sample were randomly chosen
from oral washings collected before the initial FCZ treatment and just
before every other antifungal treatment; a total of 98 isolates were
analyzed. Multilocus enzyme electrophoresis analysis revealed 14 different
electrophoretic types (ETs). Statistical analysis of genetic distances
showed that C. albicans isolates clustered into five subpopulations (I to
V). In each subpopulation, isolates are closely related, and genetic
distances between subpopulations I to IV are short. In contrast,
subpopulation V, which contained isolates typed as ET8 and ET14, is
strongly divergent from the others; these isolates may represent atypical
C. albicans isolates. Only one patient was infected with a single strain
during the course of azole therapy; for the three remaining patients,
variants of the same strain and different strains were concurrently
isolated. Clinical FCZ resistance was clearly correlated with in vitro data
for three patients. Moreover, MICs of ITZ increased during FCZ therapy, and
MICs of ITZ which were > or = 1.56 micrograms/ml were found when
clinical ITZ resistance occurred; isolates from subpopulation V showed the
highest MICs of ITZ. Because of the emergence of clinical ITZ resistance
after clinical FCZ resistance, the feasibility of long-term azole therapy
for mucosal candidiasis in AIDS patients is questioned.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities
Laboratoire d'Immunologie et Parasitologie, Faculte de Pharmacie, Montpellier, France.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|